Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
-
Narrated by:
-
By:
About this listen
Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.
Related Content:
- Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
No reviews yet